Rebuy and steaming up.

Rebuy and steaming up.

Sell high and buy low is always goal in a portfolio with an active strategy. It rarely happens, but when it does, it is just great. After a 20 % drop in the share price, I am rebuying a stock, where I have reduced my position just 1½ months ago. Also I am adding steam to my shipping stocks and …

Read more.

---
Hurtig godkendelse af Cabometyx i EU

Hurtig godkendelse af Cabometyx i EU

I dag har Exelixis og Ipsen, som er partner i Europa, annonceret at Cabometyx er godkendt. Det må siges at være meget hurtig ekspedition, hvor Ipsen først for alvor ventede gang i salget i 2017. Nu tyder alt på at Ipsen kan få et helt kvartal med salgstal. Godkendelsen udløser $60 millioner (knap 400 millioner dkk) til Exelixis, som nu bliver yderligere …

Read more.

---
BIMCO: Lowest level of newbuilding contracts in 20 years

BIMCO: Lowest level of newbuilding contracts in 20 years

The shipyards become the next victim of the deteriorating conditions in the dry bulk, container and offshore markets as 2016 looks to set the record for the lowest newbuilding contracts in more than 20 years.   After a decline from 2010 to 2012, shipbuilding had a rebound in 2013 and was expected to level out over the next few years. …

Read more.

The gateway to small- and midcap stocks in Scandinavia. Steen has more than 15 years hands-on expericence in analysing and investing in stocks. He is a weekly contributor and analyst in “Aktieugebrevet”, one of the leading sources of independent analysis in Denmark.

Peter Hildebrandt, also known as “Akademikeren”, has been investing for more than 17 years. Mainly invests in Undervalued technology and biotech stocks and is currently rotating towards dividend stocks in energy and shipping.

I’m a ten year veteran of biotechnology, and currently pursuing my MBA from UCLA.  I use my knowledge of the industry and business to make my investing decisions.  I look for small to mid-cap biotech companies with innovative research and buy into their company during clinical trials.

Andreas is providing stock tips with deep fundamental research behind each stock he recommends. He is privately a portfolio manager at his own Investment company where he Invest in stocks, options, CFD’s etc. with a balanced long/short approach.

Jacob’s approach is to search for that which is undervalued and where the discount to the intrinsic value provides a large margin of safety. He believes sectors that are either out of favor or in distress typically offer the best opportunities.